Jun 30, 2026· Comment from Association for Accessible Medicines (AAM)· FDA-2026-N-2366-0534
FDA, Please find attached comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2026-N-2366 "Commissioner's National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, AAM